NCT00652886

Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions

Compare the Relative Bioavailability of Oxandrolone 10mg Tablets With That of OXANDRIN 10 mg Tablets Following a Single Oral Dose(1*10 mg Tablet) in Healthy, Adult Subjects Under Fasting Conditions.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 26 (actual)
• Sponsor: Par Pharmaceutical, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

-To compare the single dose bioavailability of Kali and BTG

Detailed description

-To compare the bioavailability of Oxandrolone 10mg tablets with that of OXANDRIN 10mg tablets following a single -dose in healthy, adult subjects under fasting conditions.

Conditions

• To Determine the Bioequivalence Under Fasting Conditions

Interventions

Type	Name	Description
DRUG	Oxandrolone	Tablets, 10mg, single-dose
DRUG	Oxandrin	tablets, 10mg, single-dose

Timeline

• Start date: 2005-03-01
• Primary completion: 2005-03-01
• Completion: 2005-06-01
• First posted: 2008-04-04
• Last updated: 2008-04-04

Locations

1 site across 1 country: United States